澳洋健康
(002172)
| 流通市值：24.03亿 | | | 总市值：24.04亿 |
| 流通股本：7.65亿 | | | 总股本：7.66亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 581,691,001.68 | 2,173,767,566.03 | 1,623,745,504.62 | 1,063,775,243.53 |
| 营业收入 | 581,691,001.68 | 2,173,767,566.03 | 1,623,745,504.62 | 1,063,775,243.53 |
| 二、营业总成本 | 541,279,571.75 | 2,118,225,391.37 | 1,567,851,006.21 | 1,023,886,303.38 |
| 营业成本 | 501,631,418.01 | 1,880,631,380.05 | 1,397,580,622.77 | 910,841,657.95 |
| 税金及附加 | 2,552,656.57 | 11,011,829.35 | 8,204,675.79 | 5,300,133.32 |
| 销售费用 | 10,239,875.05 | 49,239,183.85 | 36,789,275.31 | 25,874,291.05 |
| 管理费用 | 30,094,776.78 | 144,443,830.79 | 97,560,377.11 | 65,043,323.84 |
| 研发费用 | - | - | 1,688,589.75 | 1,147,695.46 |
| 财务费用 | -3,239,154.66 | 32,899,167.33 | 26,027,465.48 | 15,679,201.76 |
| 其中:利息费用 | 12,844,516.94 | 43,185,135.58 | 31,416,628.51 | 22,498,623.59 |
| 其中:利息收入 | 18,925,321.04 | 24,424,521.67 | 21,205,056.13 | 16,230,109.88 |
| 加:投资收益 | -386,950.6 | 20,766,204.27 | 22,732,355.81 | 22,635,812.93 |
| 资产处置收益 | -51.66 | 29,446.76 | 31,463.34 | -1,961.05 |
| 信用减值损失(新) | -4,465,533.43 | 556,838.35 | 591,498.12 | 7,194,308.75 |
| 其他收益 | 396,939.05 | 5,091,542.11 | 1,615,134.69 | 1,055,882.78 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 35,955,833.29 | 81,986,206.15 | 80,864,950.37 | 70,772,983.56 |
| 加:营业外收入 | 4,274,558.44 | 13,436,219.86 | 5,697,901.03 | 1,882,870.46 |
| 减:营业外支出 | 1,419,476.54 | 25,477,949.72 | 23,729,540.31 | 22,773,362.94 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 38,810,915.19 | 69,944,476.29 | 62,833,311.09 | 49,882,491.08 |
| 减:所得税费用 | 7,673,089.57 | 19,681,089.89 | 22,881,135.82 | 14,046,180.25 |
| 六、净利润 | 31,137,825.62 | 50,263,386.4 | 39,952,175.27 | 35,836,310.83 |
| 持续经营净利润 | 31,137,825.62 | 50,263,386.4 | 39,952,175.27 | 35,836,310.83 |
| 归属于母公司股东的净利润 | 30,739,368.29 | 49,681,623.57 | 39,667,231.19 | 35,465,167.67 |
| 少数股东损益 | 398,457.33 | 581,762.83 | 284,944.08 | 371,143.16 |
| (一)基本每股收益 | 0.04 | 0.06 | 0.05 | 0.05 |
| (二)稀释每股收益 | 0.04 | 0.06 | 0.05 | 0.05 |
| 九、综合收益总额 | 31,137,825.62 | 50,263,386.4 | 39,952,175.27 | 35,836,310.83 |
| 归属于母公司股东的综合收益总额 | 30,739,368.29 | 49,681,623.57 | 39,667,231.19 | 35,465,167.67 |
| 归属于少数股东的综合收益总额 | 398,457.33 | 581,762.83 | 284,944.08 | 371,143.16 |
| 公告日期 | 2024-04-30 | 2024-04-27 | 2023-10-25 | 2023-08-26 |
| 审计意见(境内) | | 标准无保留意见 | | |